Study type: Human research · Status: Verified against declared source

The mechanism of transcutaneous gastric pacing treatment on gastrointestinal motility recovery and inflammation improvement in early-stage acute pancreatitis patients.

BMC gastroenterology · 2024

Study scale: Acute pancreatitis (AP) is caused by the activation of pancreatic enzymes.

Abstract only: Open source record

Product or molecular entity relationships

VIP: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Acute pancreatitis (AP) is often accompanied by gastrointestinal motility disorders.

Methods

After admission, the enrolled patients were divided into two groups by SPSS computer randomization method: one group was TGP group, and the other group was conventional treatment group.

Scale or participants

Acute pancreatitis (AP) is caused by the activation of pancreatic enzymes.

Key findings

Compared with the conventional treatment group, the TGP treatment significantly improved symptoms in early AP patients, and shortened the first defecation time (p < 0.05) and the hospital days (p < 0.05).

Limitations and uncertainty

The inflammatory factors in TGP group showed a downward trend after treatment, among which WBC, CRP, IL-6 and TNF-α showed statistically significant difference (Fig.

Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.